Alpha Innotech Corp.

Bill is co-founder and Managing Partner at BroadOak. Mr. Snider has over 15 years of institutional investment experience. Prior to BroadOak, he was a general partner and co-founder of Emerging Technology Partners, LLC, a life sciences focused venture capital firm. He has invested in over 20 life science companies while at ETP of which more than half were or are now publicly traded. Mr. Snider, at various times, acted as lead investor, board member and chairman for ETP's portfolio companies. Prior to ETP he was a vice president and portfolio manager at T. Rowe Price. His responsibilities included managing $2 billion of mutual fund and institutional client portfolios. Mr. Snider's current and past directorships include Alpha Innotech, Atto Biosciences and Marligen Biosciences. Bill holds the Chartered Financial Analysts accreditation, a B.S. in Finance and an M.B.A. from the Wharton School at the University of Pennsylvania.

Haseeb Chaudhry, co-founded Alpha Innotech and became its director and Chief Executive Officer in 1992. Mr. Chaudhry has over 14 years of experience in strategic planning, business development, sales and marketing and managing technology and application development. Prior to founding Alpha Innotech, Mr. Chaudhry was involved with a start-up biotech company, American Synthesis, where he sold and marketed customized oligonucleotides, reagents, chemicals and scientific instruments. Mr. Chaudhry has participated in various start-up ventures in retail, industrial services and international training. He holds a BA in Genetics from the University of California, Berkeley.